Acute generalized exanthematic pustulosis: A case and an overview of side effects affecting the skin caused by celecoxib and other COX-2 inhibitors reported so far

Dermatology

Volumn 209, Issue 1, 2004, Pages 53-56

  Goeschke, B ^a,b   Braathen, L R ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b TRIEMLI HOSPITAL   (Switzerland)

Author keywords

Acute generalized exanthematic pustulosis; Celecoxib; Cyclooxygenase type 2 inhibitors; Drug reactions affecting the skin

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR;

ACUTE GENERALIZED EXANTHEMATIC PUSTULOSIS; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HUMEROSCAPULAR PERIARTHRITIS; LABORATORY TEST; PRIORITY JOURNAL; PUSTULOSIS; TREATMENT OUTCOME;

ARM; ARTHRITIS; CYCLOOXYGENASE INHIBITORS; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; EXANTHEMA; FACE; FEMALE; HUMANS; MIDDLE AGED; PYRAZOLES; SULFONAMIDES;

EID: 4444282446     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078588     Document Type: Article

References (37)

1. Beylot C, Bioulac P, Doutre MS: Acute generalized exanthematic pustuloses: Four cases (in French). Ann Dermatol Vénéréol 1980;107:37-48.
2. Stanley J: Phenytoin hypersensitivity reaction. Arch Dermatol 1978;114:1350-1353.
3. Yip J, Sheehan-Dare R, Cotterill J: Toxic pustuloderma due to PUVA treatment. Br J Dermatol 1991;125:401-402.
4. Brouard MC, Prins C, Mach-Pascual S, Saurat JH: Acute generalized exanthematous pustulosis associated with STI571 in a patient with chronic myeloid leukaemia. Dermatology 2001;203:57-59.
5. Armster H, Schwarz T: Arzneimittelreaktion auf Amoxicillin unter dem Bild eines toxischen Pustuloderms. Hautarzt 1991;42:713-716.
6. Röckl H: Medikamentenallergische Vasculitis leucocytoclastica unter dem Bild eines generalisierten pustulösen Exanthems. Hautarzt 1981;32:467-470.
7. Roujeau JC, Bioulac-Sage P, Bourseau C, Guillaume JC, Bernard P, Lok C, Plantin B, Claudy A, Delavierre C, Vaillant L, Wechsler J, Danan G, Bénichou C, Beylot C: Acute generalized exanthematous pustulosis. Arch Dermatol 1991;127:1333-1338.
8. Rustin MAH, Robinson TWE, Dowd P: Toxic pustuloderma: A self-limiting eruption. Br J Dermatol 1990;123:119-124.
9. Süss R, Korting H: Generalized pustular drug rash. Eur J Dermatol 1994;5:351-353.
10. Skowron F, Bérard F, Bernard N, Balme B, Perrot H: Cutaneous vasculitis related to celecoxib. Dermatology 2002;204:305.
11. Levy MB, Fink JN: Anaphylaxis to celecoxib. Ann Allergy Asthma Immunol 2001;87:72-73.
12. Bavbek S, Celik G, Ediger D, Mungan D, Demirel YS, Misirligil Z: The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti-inflammatory drug intolerance. J Asthma 1999;36:657-663.
13. Sanchez Borges M, Capriles-Hulett A, Caballero-Fonseca F, Perez CR: Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions. Ann Allergy Asthma Immunol 2001;87:201-204.
14. Carder KR, Weston WL: Rofecoxib-induced instant aquagenic wrinkling of the palms. Pediatr Dermatol 2002;19:353-355.
15. Grob M, Scheidegger P, Wüthrich B: Allergic skin reaction to celecoxib. 2000;201:383.
16. Verbeiren S, Morant C, Charlanne H, Ajebbar K, Caron J, Modiano P: Celecoxib induced toxiderma with positive patch test. Ann Dermatol Vénéréol 2002;129:203-204.
17. Fradet G, Robin-Le Nechet A, Huguenin H, Chiffoleau A: Hypersensitivity to celecoxib. Ann Méd Interne (Paris) 2003;154:181-182.
18. Nedorost ST, Florentino FT, Gillian AC: Fixed drug eruption to rofecoxib. Cutis 2002;70:125-126.
19. Bandyopadhyay D: Celecoxib-induced fixed drug eruption. Clin Exp Dermatol 2003;28:452.
20. Poza-Guedes P, Gonzales-Perez R, Canto G: Celecoxib-induced lupus-like syndrome. Rheumatology (Oxford) 2003;42:916-917.
21. Simon LS, Weaver AL, Graham DY, Kivitz AJ, Lipsky PE, Hubbard RC, Isakson PC, Verburg KM, Yu SS, Zhao WW, Geis GS: Antiinflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial. JAMA 1999;282:1921.
22. Cummins R, Wagner-Weiner L, Paller A: Pseudoporphyria induced by celecoxib in a patient with juvenile rheumatoid arthritis. J Rheumatol 2000;27:2938-2940.
23. Clark DW, Coulter DM: Psoriasis associated with rofecoxib. Arch Dermatol 2003;139:1223.
24. Fye KH, Crowley E, Berger TG, Le Boit PE, Connolly MK: Celecoxib-induced Sweet's syndrome. J Am Acad Dermatol 2001;45:300-302.
25. Berger P, Dwyler D, Corallo CE: Toxic epidermal necrolysis after celecoxib therapy. Pharmacotherapy 2002;22:1193-1195.
26. Friedman B, Orlet HK, Still JM, Law E: Toxic epidermal necrolysis due to administration of celecoxib (Celebrex). South Med J 2002;95:1213-1214.
27. Glasser DL, Burroughs SH: Valdecoxib-induced toxic epidermal necrolysis in a patient allergic to sulfa drugs. Pharmacotherapy 2003;23:551-553.
28. Crofford LJ, Oates JC, McCune WJ, Gupta S, Kaplan MJ, Catella-Lawson F, Morrow JD, McDonagh KT, Schmaier AH: Thrombosis in a patient with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors. Arthritis Rheum 2000;43:1891-1896.
29. Kelkar PS, Butterfield JH, Teaford HG: Urticaria and angioedema from cyclooxygenase 2 inhibitors. J Rheumatol 2001;28:2553-2554.
30. Gscheidel D, Daspet MK, le Coz CJ, Lipsker D: Allergic vasculitis following ingestion of celecoxib. Hautarzt 2002;53:488-491.
31. Schneider F, Meziani F, Chartier C, Alt M, Jaeger A: Fatal allergic vasculitis associated with celecoxib. Lancet 2002;359:852-853.
32. Litt JZ: Drug Eruption Reference Manual. New York, Partenon Publishing Group, 2001, p 305.
33. Wiholm BE: Identification of sulphonamidelike adverse drug reactions to celecoxib in the World Health Organisation database. Curr Med Res Opin 2001;17:210-216.
34. Shapiro LE, Knowles SR, Weber E, Neuman MG, Shear NH: Safety of celecoxib in individuals allergic to sulphonamide, a pilot study. Drug Saf 2003;26:187-195.
35. Knowles S, Shapiro L, Shear NH: Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of 'sulfa' allergy. Drug Saf 2001;24:239-247.
36. Kaur: Fixed drug eruption to rofecoxib with cross-reactivity to sulfonamides. Dermatology 2001;203:351.
37. Crofford LJ, Oates JC, McCune WJ, Gupta S, Kaplan Mj, Catella-Lawson F, Morrow JD, McDonagh KT, Schmaier AH: Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors: A report of four cases. Arthritis Rheum 2000;43:1891-1896.